1 Report Overview

　1.1 Research Scope

　1.2 Top mRNA Vaccines & Therapeutianufacturers Covered: Ranking by Revenue

　1.3 Market Segment by Type

　　1.3.1 Global mRNA Vaccines & Therapeutiarket Size by Type: 2015 VS 2020 VS 2026 (US$ Million)

　　1.3.2 Standardization Of Cancer Treatment MRNA Vaccine

　　1.3.3 Individualized Cancer Treatment MRNA Vaccine

　　1.3.4 Infectious Disease Treatment MRNA Vaccine

　　1.3.5 Infection Prevention MRNA Vaccine

　1.4 Market Segment by Application

　　1.4.1 Global mRNA Vaccines & Therapeutics Consumption by Application: 2015 VS 2020 VS 2026

　　1.4.2 Infectious Disease

　　1.4.3 Cancer

　　1.4.4 Other

　1.5 Study Objectives

　1.6 Years Considered

2 Global Market Perspective

　2.1 Global mRNA Vaccines & Therapeutics Revenue (2015-2026)

　　2.1.1 Global mRNA Vaccines & Therapeutics Revenue (2015-2026)

　　2.1.2 Global mRNA Vaccines & Therapeutics Sales (2015-2026)

　2.2 mRNA Vaccines & Therapeutiarket Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026

　　2.2.1 Global mRNA Vaccines & Therapeutics Sales by Regions (2015-2020)

　　2.2.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020)

　2.3 Global Top mRNA Vaccines & Therapeutics Regions (Countries) Ranking by Market Size

　2.4 mRNA Vaccines & Therapeutics Industry Trends

　　2.4.1 mRNA Vaccines & Therapeutiarket Top Trends

　　2.4.2 Market Drivers

　　2.4.3 mRNA Vaccines & Therapeutiarket Challenges

　　2.4.4 Porter's Five Forces Analysis

　　2.4.5 Primary Interviews with Key mRNA Vaccines & Therapeutics Players: Views for Future

3 Competitive Landscape by Manufacturers

　3.1 Global Top mRNA Vaccines & Therapeutianufacturers by Sales (2015-2020)

　　3.1.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2015-2020)

　　3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2015-2020)

　　3.1.3 Global 5 and 10 Largest Manufacturers by mRNA Vaccines & Therapeutics Sales in 2019

　3.2 Global Top Manufacturers mRNA Vaccines & Therapeutics by Revenue

　　3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2015-2020)

　　3.2.2 Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020)

　　3.2.3 Global mRNA Vaccines & Therapeutiarket Concentration Ratio (CR5 and HHI)

　3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)

　3.4 Global mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Manufacturers

　3.5 Key Manufacturers mRNA Vaccines & Therapeutics Plants/Factories Distribution and Area Served

　3.6 Date of Key Manufacturers Enter into mRNA Vaccines & Therapeutiarket

　3.7 Key Manufacturers mRNA Vaccines & Therapeutics Product Offered

　3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

　4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2015-2020)

　　4.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　　4.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2015-2020)

詳^情：http://www.qdlaimaiche.com/0/09/Global-mRNA-Vaccines-Therapeutics-Industry-Research-Report-Growth-Trends-and-Competitive.html

　　4.1.4 mRNA Vaccines & Therapeutics Price by Type (2015-2020)

　4.1 Global mRNA Vaccines & Therapeutiarket Estimates and Forecasts by Type (2021-2026)

　　4.2.2 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026)

　　4.2.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026)

　　4.2.4 mRNA Vaccines & Therapeutics Price Forecast by Type (2021-2026)

5 Global mRNA Vaccines & Therapeutiarket Size by Application

　5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2015-2020)

　　5.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　　5.1.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)

　　5.1.4 mRNA Vaccines & Therapeutics Price by Application (2015-2020)

　5.2 Global mRNA Vaccines & Therapeutiarket Estimates and Forecasts by Application (2021-2026)

　　5.2.2 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026)

　　5.2.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026)

　　5.2.4 mRNA Vaccines & Therapeutics Price Forecast by Application (2021-2026)

6 North America

　6.1 North America mRNA Vaccines & Therapeutics Breakdown Data by Company

　6.2 North America mRNA Vaccines & Therapeutics Breakdown Data by Type

　6.3 North America mRNA Vaccines & Therapeutics Breakdown Data by Application

　6.4 North America mRNA Vaccines & Therapeutics Breakdown Data by Countries

　　6.4.1 North America mRNA Vaccines & Therapeutics Sales by Countries

　　6.4.2 North America mRNA Vaccines & Therapeutics Revenue by Countries

　　6.4.3 U.S.

　　6.4.4 Canada

7 Europe

　7.1 Europe mRNA Vaccines & Therapeutics Breakdown Data by Company

　7.2 Europe mRNA Vaccines & Therapeutics Breakdown Data by Type

　7.3 Europe mRNA Vaccines & Therapeutics Breakdown Data by Application

　7.4 Europe mRNA Vaccines & Therapeutics Breakdown Data by Countries

　　7.4.1 Europe mRNA Vaccines & Therapeutics Sales by Countries

　　7.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries

　　7.4.3 Germany

　　7.4.4 France

　　7.4.5 U.K.

　　7.4.6 Italy

　　7.4.7 Russia

8 Asia Pacific

　8.1 Asia PacifiA Vaccines & Therapeutics Breakdown Data by Company

　8.2 Asia PacifiA Vaccines & Therapeutics Breakdown Data by Type

　8.3 Asia PacifiA Vaccines & Therapeutics Breakdown Data by Application

　8.4 Asia PacifiA Vaccines & Therapeutics Breakdown Data by Regions

　　8.4.1 Asia PacifiA Vaccines & Therapeutics Sales by Regions

　　8.4.2 Asia PacifiA Vaccines & Therapeutics Revenue by Regions

　　8.4.3 China

　　8.4.4 Japan

　　8.4.5 South Korea

　　8.4.6 India

　　8.4.7 Australia

　　8.4.8 Taiwan, China

　　8.4.9 Indonesia

　　8.4.10 Thailand

　　8.4.11 Malaysia

　　8.4.12 Philippines

　　8.4.13 Vietnam

9 Latin America

　9.1 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Company

　9.2 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Type

　9.3 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Application

　9.4 Latin America mRNA Vaccines & Therapeutics Breakdown Data by Countries

　　9.4.1 Latin America mRNA Vaccines & Therapeutics Sales by Countries

　　9.4.2 Latin America mRNA Vaccines & Therapeutics Revenue by Countries

　　9.4.3 Mexico

　　9.4.4 Brazil

　　9.4.5 Argentina

10 Middle East and Africa

　10.1 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Type

　10.2 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Application

　10.3 Middle East and Africa mRNA Vaccines & Therapeutics Breakdown Data by Countries

　　10.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries

　　10.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries

　　10.3.3 Turkey

　　10.3.4 Saudi Arabia

　　10.3.5 U.A.E

11 Company Profiles

　11.1 Company 1

　　11.1.1 Company 1 Corporation Information

　　11.1.2 Company 1 Business Overview and Total Revenue (2019 VS 2018)

　　11.1.3 Moderna TherapeutiRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.1.4 Moderna TherapeutiRNA Vaccines & Therapeutics Products and Services

　　11.1.5 Company 1 SWOT Analysis

　　11.1.6 Company 1 Recent Developments

　11.2 Company 2

　　11.2.1 Company 2 Corporation Information

　　11.2.2 Company 2 Business Overview and Total Revenue (2019 VS 2018)

　　11.2.3 CureVaA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.2.4 CureVaA Vaccines & Therapeutics Products and Services

　　11.2.5 Company 2 SWOT Analysis

　　11.2.6 Company 2 Recent Developments

　11.3 Company 3

　　11.3.1 Company 3 Corporation Information

　　11.3.2 Company 3 Business Overview and Total Revenue (2019 VS 2018)

　　11.3.3 Company 3 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.3.4 Company 3 mRNA Vaccines & Therapeutics Products and Services

　　11.3.5 Company 3 SWOT Analysis

　　11.3.6 Company 3 Recent Developments

　11.4 Company 4

　　11.4.1 Company 4 Corporation Information

　　11.4.2 Company 4 Business Overview and Total Revenue (2019 VS 2018)

　　11.4.3 Company 4 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.4.4 Company 4 mRNA Vaccines & Therapeutics Products and Services

全球疫苗基因及藥物治療行業(yè)研究報告，增長趨勢和競爭分析2020年至2026年

　　11.4.5 Company 4 SWOT Analysis

　　11.4.6 Company 4 Recent Developments

　11.5 Company 5

　　11.5.1 Company 5 Corporation Information

　　11.5.2 Company 5 Business Overview and Total Revenue (2019 VS 2018)

　　11.5.3 Sangamo TherapeutiRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.5.4 Sangamo TherapeutiRNA Vaccines & Therapeutics Products and Services

　　11.5.5 Company 5 SWOT Analysis

　　11.5.6 Company 5 Recent Developments

　11.6 Company 6

　　11.6.1 Company 6 Corporation Information

　　11.6.2 Company 6 Business Overview and Total Revenue (2019 VS 2018)

　　11.6.3 Argos TherapeutiRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.6.4 Argos TherapeutiRNA Vaccines & Therapeutics Products and Services

　　11.6.5 Company 6 SWOT Analysis

　　11.6.6 Company 6 Recent Developments

　11.7 Company 7

　　11.7.1 Company 7 Corporation Information

　　11.7.2 Company 7 Business Overview and Total Revenue (2019 VS 2018)

　　11.7.3 Company 7 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.7.4 Company 7 mRNA Vaccines & Therapeutics Products and Services

　　11.7.5 Company 7 SWOT Analysis

　　11.7.6 Company 7 Recent Developments

　11.8 Company 8

　　11.8.1 Company 8 Corporation Information

　　11.8.2 Company 8 Business Overview and Total Revenue (2019 VS 2018)

　　11.8.3 Company 8 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.8.4 Company 8 mRNA Vaccines & Therapeutics Products and Services

　　11.8.5 Company 8 SWOT Analysis

　　11.8.6 Company 8 Recent Developments

　11.9 Company 9

　　11.9.1 Company 9 Corporation Information

　　11.9.2 Company 9 Business Overview and Total Revenue (2019 VS 2018)

　　11.9.3 Company 9 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.9.4 Company 9 mRNA Vaccines & Therapeutics Products and Services

　　11.9.5 Company 9 SWOT Analysis

　　11.9.6 Company 9 Recent Developments

　11.10 Company 10

　　11.10.1 Company 10 Corporation Information

　　11.10.2 Company 10 Business Overview and Total Revenue (2019 VS 2018)

　　11.10.3 Company 10 mRNA Vaccines & Therapeutics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)

　　11.10.4 Company 10 mRNA Vaccines & Therapeutics Products and Services

　　11.10.5 Company 10 SWOT Analysis

　　11.10.6 Company 10 Recent Developments

12 Supply Chain and Sales Channels Analysis

　12.1 Supply Chain Analysis

　12.2 Sales Channels Analysis

　　12.2.1 mRNA Vaccines & Therapeutics Sales Channels

　　12.2.2 mRNA Vaccines & Therapeutics Distributors

　12.3 mRNA Vaccines & Therapeutics Customers

13 Estimates and Projections by Regions (2021-2026)

　13.1 Global mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.1.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2021-2026)

　　13.1.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions (2021-2026)

　13.2 North America Market Size Forecast (2021-2026)

　　13.2.1 North America mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.2.2 North America mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)

　　13.2.3 North America mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)

　13.3 Europe Market Size Forecast (2021-2026)

　　13.3.1 Europe mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.3.2 Europe mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)

　　13.3.3 Europe mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)

　13.4 Asia Pacific Market Size Forecast (2021-2026)

　　13.4.1 Asia PacifiA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.4.2 Asia PacifiA Vaccines & Therapeutics Revenue Forecast (2021-2026)

　　13.4.3 Asia PacifiA Vaccines & Therapeutics Size Forecast by Region (2021-2026)

　13.5 Latin America Market Size Forecast (2021-2026)

　　13.5.1 Latin America mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.5.2 Latin America mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)

　　13.5.3 Latin America mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)

　13.6 Middle East and Africa Market Forecast

　　13.6.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast (2021-2026)

　　13.6.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue Forecast (2021-2026)

　　13.6.3 Middle East and Africa mRNA Vaccines & Therapeutics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix

　15.1 Research Methodology

　　15.1.1 Methodology/Research Approach

　　15.1.2 Data Source

　15.2 Author Details

　15.3 Disclaimer

List of Tables

　Table 1. mRNA Vaccines & Therapeutics Key Market Segments

　Table 2. Ranking of Global Top mRNA Vaccines & Therapeutianufacturers by Revenue (US$ Million) in 2019

　Table 3. Global mRNA Vaccines & Therapeutiarket Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)

　Table 4. Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine

　Table 5. Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine

　Table 6. Major Manufacturers of Infectious Disease Treatment MRNA Vaccine

　Table 7. Major Manufacturers of Infection Prevention MRNA Vaccine

　Table 8. Global mRNA Vaccines & Therapeutiarket Share by Application 2019-2025 (K Units)

　Table 9. Global mRNA Vaccines & Therapeutiarket Size by Regions 2015-2020 (K Units) & (Million US$)

　Table 10. Global mRNA Vaccines & Therapeutics Sales by Regions 2015-2020 (K Units)

　Table 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions 2015-2020

　Table 12. Global mRNA Vaccines & Therapeutics Revenue by Regions 2015-2020 (Million US$)

　Table 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions 2015-2020

　Table 14. Top mRNA Vaccines & Therapeutics Regions (Countries) Ranking by Market Size (US$ Million) in 2019

　Table 15. Market Top Trends

全球疫苗基因及藥物治療行業(yè)研究報告，增長趨勢和競爭分析2020年至2026年

　Table 16. mRNA Vaccines & Therapeutics Key Drivers: Impact Analysis (2021-2026)

　Table 17. mRNA Vaccines & Therapeutics Key Challenges

　Table 18. Main Points Interviewed from Key mRNA Vaccines & Therapeutics Players: Views for Future

　Table 19. Global mRNA Vaccines & Therapeutics Sales by Manufacturers (2015-2020) (K Units)

　Table 20. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers (2015-2020)

　Table 21. mRNA Vaccines & Therapeutics Revenue by Manufacturers (2015-2020) (Million US$)

　Table 22. mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2015-2020)

　Table 23. Global mRNA Vaccines & Therapeutianufacturers Market Concentration Ratio (CR5 and HHI)

　Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)

　Table 25. Key Manufacturers mRNA Vaccines & Therapeutics Average Selling Price (ASP) (2015-2020) (USD/Unit)

　Table 26. Key Manufacturers mRNA Vaccines & Therapeutics Plants/Factories Distribution

　Table 27. Key Manufacturers mRNA Vaccines & Therapeutics Area Served

　Table 28. Date of Key Manufacturers Enter into mRNA Vaccines & Therapeutiarket

　Table 29. Key Manufacturers mRNA Vaccines & Therapeutics Product Type

　Table 30. Mergers & Acquisitions, Expansion Plans

　Table 31. Global Standardization Of Cancer Treatment MRNA Vaccine Sales and Revenue (2015-2020) (K Units) & (Million US$)

　Table 32. Global Individualized Cancer Treatment MRNA Vaccine Sales and Revenue (2015-2020) (K Units) & (Million US$)

　Table 33. Global Infectious Disease Treatment MRNA Vaccine Sales ana Revenue (2015-2020) (K Units) & (Million US$)

　Table 34. Global Infection Prevention MRNA Vaccine Sales ana Revenue (2015-2020) (K Units) & (Million US$)

　Table 35. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)

　Table 36. Global mRNA Vaccines & Therapeutics Sales Share by Type (2015-2020)

　Table 37. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)

　Table 38. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2015-2020)

　Table 39. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2021-2026)

　Table 40. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)

　Table 41. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)

　Table 42. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)

　Table 43. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2021-2026)

　Table 44. Global mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)

　Table 45. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)

　Table 46. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)

　Table 47. Global mRNA Vaccines & Therapeutics Price by Application 2015-2020 (USD/Unit)

　Table 48. Global mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 49. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)

　Table 50. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)

　Table 51. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2026)

　Table 52. Global mRNA Vaccines & Therapeutics Price (K Units) by Application (2021-2026)

　Table 53. North America mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)

　Table 54. North America mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)

　Table 55. North America mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

　Table 56. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　Table 57. North America mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 58. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　Table 59. North America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

　Table 60. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

　Table 61. North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)

　Table 62. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

　Table 63. Europe mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)

　Table 64. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)

　Table 65. Europe mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

　Table 66. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　Table 67. Europe mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 68. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　Table 69. Europe mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

　Table 70. Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

　Table 71. Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)

　Table 72. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

　Table 73. Asia PacifiA Vaccines & Therapeutics Sales by Regions (2015-2020) (K Units)

　Table 74. Asia PacifiA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)

　Table 75. Asia PacifiA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

　Table 76. Asia PacifiA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　Table 77. Asia PacifiA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 78. Asia PacifiA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　Table 79. Asia PacifiA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

　Table 80. Asia PacifiA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)

　Table 81. Asia PacifiA Vaccines & Therapeutics Revenue by Regions (2015-2020) (Million US$)

　Table 82. Asia PacifiA Vaccines & Therapeutics Revenue Market Share by Regions (2015-2020)

　Table 83. Latin America mRNA Vaccines & Therapeutics Sales by Company (2015-2020) (K Units)

　Table 84. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)

　Table 85. Latin America mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

　Table 86. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　Table 87. Latin America mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 88. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　Table 89. Latin America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

　Table 90. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

　Table 91. Latin America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)

　Table 92. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

　Table 93. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

　Table 94. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

　Table 95. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

　Table 96. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

　Table 97. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

　Table 98. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

　Table 99. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (Million US$)

　Table 100. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

　Table 101. Company 1 Company Details

　Table 102. Company 1 Description and Business Overview

　Table 103. Moderna TherapeutiRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 104. Moderna TherapeutiRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 105. Moderna TherapeutiRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 106. Company 1 Recent Development

　Table 107. Company 2 Company Details

　Table 108. Company 2 Description and Business Overview

　Table 109. CureVaA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 110. CureVaA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 111. CureVaA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 112. Company 2 Recent Development

　Table 113. Company 3 Company Details

quánqiú yìmiáo jīyīn jí yàowù zhìliáo hángyè yán jiù bàogào, zēngzhǎng qūshì hé jìngzhēng fēnxī 2020 nián zhì 2026 nián

　Table 114. Company 3 Description and Business Overview

　Table 115. Company 3 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 116. Company 3 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 117. Company 3 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 118. Company 3 Recent Development

　Table 119. Company 4 Company Details

　Table 120. Company 4 Description and Business Overview

　Table 121. Company 4 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 122. Company 4 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 123. Company 4 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 124. Company 4 Recent Development

　Table 125. Company 5 Company Details

　Table 126. Company 5 Description and Business Overview

　Table 127. Sangamo TherapeutiRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 128. Sangamo TherapeutiRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 129. Sangamo TherapeutiRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 130. Company 5 Recent Development

　Table 131. Company 6 Company Details

　Table 132. Company 6 Description and Business Overview

　Table 133. Argos TherapeutiRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 134. Argos TherapeutiRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 135. Argos TherapeutiRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 136. Company 6 Recent Development

　Table 137. Company 7 Company Details

　Table 138. Company 7 Description and Business Overview

　Table 139. Company 7 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 140. Company 7 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 141. Company 7 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 142. Company 7 Recent Development

　Table 143. Company 8 Company Details

　Table 144. Company 8 Description and Business Overview

　Table 145. Company 8 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 146. Company 8 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 147. Company 8 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 148. Company 8 Recent Development

　Table 149. Company 9 Company Details

　Table 150. Company 9 Description and Business Overview

　Table 151. Company 9 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 152. Company 9 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 153. Company 9 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 154. Company 9 Recent Development

　Table 155. Company 10 Company Details

　Table 156. Company 10 Description and Business Overview

　Table 157. Company 10 mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

　Table 158. Company 10 mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020)

　Table 159. Company 10 mRNA Vaccines & Therapeutics Sales Market Share in Global Market

　Table 160. Company 10 Recent Development

　Table 161. mRNA Vaccines & Therapeutics Distributors List

　Table 162. mRNA Vaccines & Therapeutics Customers List

　Table 163. Global mRNA Vaccines & Therapeutics Sales Forecast 2021-2026 (K Units) & (Million US$)

　Table 164. Global mRNA Vaccines & Therapeutics Sales Forecast by Type 2021-2026 (K Units)

　Table 165. Global mRNA Vaccines & Therapeutics Sales Forecast by Application 2021-2026 (K Units)

　Table 166. Global mRNA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)

　Table 167. Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)

　Table 168. North America mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)

　Table 169. North America mRNA Vaccines & Therapeutics Revenue Forecast by Countries 2021-2026

　Table 170. Europe mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)

　Table 171. Europe mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Countries 2021-2026

　Table 172. Asia PacifiA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)

　Table 173. Asia PacifiA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)

　Table 174. Latin America mRNA Vaccines & Therapeutics Sales Forecast by Countries 2021-2026 (K Units)

　Table 175. Latin America mRNA Vaccines & Therapeutics Revenue Forecast by Countries 2021-2026 (Million US$)

　Table 176. Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast by Regions 2021-2026 (K Units)

　Table 177. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Forecast by Regions 2021-2026 (Million US$)

　Table 178. Research Programs/Design for This Report

　Table 179. Key Data Information from Secondary Sources

　Table 180. Key Data Information from Primary Sources

List of Figures

　Figure 1. mRNA Vaccines & Therapeutics Product Picture

　Figure 2. Global mRNA Vaccines & Therapeutics Sales Market Shar by Type 2015-2026

　Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Figures

　Figure 4. Individualized Cancer Treatment MRNA Vaccine Figures

　Figure 5. Infectious Disease Treatment MRNA Vaccine Figures

　Figure 6. Infection Prevention MRNA Vaccine Figures

　Figure 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019 & 2026

　Figure 8. Infectious Disease Use Case

　Figure 9. Cancer Use Case

　Figure 10. Other Use Case

　Figure 11. mRNA Vaccines & Therapeutics Report Years Considered

　Figure 12. Global mRNA Vaccines & Therapeutiarket Size 2015-2026 (Million US$)

　Figure 13. Global mRNA Vaccines & Therapeutics Sales 2015-2020 (K Units)

　Figure 14. Global mRNA Vaccines & Therapeutiarket Size Market Share by Regions 2015-2020

　Figure 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2019

　Figure 16. Porter's Five Forces Analysis

　Figure 17. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturers in 2019

　Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Vaccines & Therapeutics Sales in 2019

　Figure 19. mRNA Vaccines & Therapeutics Value Share by Manufacturers in 2019

　Figure 20. mRNA Vaccines & Therapeutics Revenue Share by Manufacturers In 2019

　Figure 21. mRNA Vaccines & Therapeutiarket Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

　Figure 22. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)

　Figure 23. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Type in 2015 & 2019

　Figure 24. Global mRNA Vaccines & Therapeutiarket Share by Price Range (2015-2020)

　Figure 25. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2015-2020)

　Figure 26. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Application in 2015 & 2019

　Figure 27. North America mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)

　Figure 28. U.S. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 29. Canada mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 30. Europe mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)

グローバルのmRNAワクチン＆Therapeuticsの業(yè)界研究報告書、成長動向と競合分析2020-2026

　Figure 31. Germany mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 32. France mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 33. U.K. mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 34. Italy mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 35. Russia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 36. Asia PacifiA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)

　Figure 37. China mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 38. Japan mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 39. South Korea mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 40. India mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 41. Australia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 42. Taiwan, China mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 43. Indonesia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 44. Thailand mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 45. Malaysia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 46. Philippines mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 47. Vietnam mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 48. Latin America mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)

　Figure 49. Mexico mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 50. Brazil mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 51. Argentina mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 52. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Growth Rate 2015-2020 (Million US$)

　Figure 53. Turkey mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 54. Saudi Arabia mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 55. U.A.E mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2020) (K Units)

　Figure 56. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 57. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 58. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 59. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 60. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 61. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 62. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 63. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 64. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 65. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018

　Figure 66. mRNA Vaccines & Therapeutics Value Chain

　Figure 67. Channels of Distribution

　Figure 68. Distributors Profiles

　Figure 69. North America mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)

　Figure 70. North America mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)

　Figure 71. Europe mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)

　Figure 72. Europe mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)

　Figure 73. Asia PacifiA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)

　Figure 74. Asia PacifiA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)

　Figure 75. Latin America mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)

　Figure 76. Latin America mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)

　Figure 77. Middle East and Africa mRNA Vaccines & Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)

　Figure 78. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)

　Figure 79. Bottom-up and Top-down Approaches for This Report

　Figure 80. Data Triangulation

　Figure 81. Key Executives Interviewed

　　http://www.qdlaimaiche.com/0/09/Global-mRNA-Vaccines-Therapeutics-Industry-Research-Report-Growth-Trends-and-Competitive.html

　　略……